NCT02287233 2022-08-29A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous LeukemiaAbbViePhase 1/2 Completed94 enrolled 37 charts
NCT00129168 2008-04-01Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)Kanisa PharmaceuticalsPhase 1/2 Completed100 enrolled